Syntheses and anti-cancer activities of 2-[1-(indo1-3-yl-/pyrimidin-5-yl-/pyridine-2-yl-/quinolin-2-yl)-but-3-enylaminol-2-phenyl-ethanols

被引:34
作者
Singh, Palwinder [1 ]
Kaur, Pervinder
Luxami, Vijay
Kaur, Satwinderjit
Kumar, Subodh
机构
[1] Guru Nanak Dev Univ, Dept Chem, Amritsar 143005, Punjab, India
[2] Guru Nanak Dev Univ, Dept Bot & Environm Sci, Amritsar 143005, Punjab, India
关键词
heterocycles; Schiff bases; indium; allylation; in vitro; anti-cancer activities;
D O I
10.1016/j.bmc.2007.01.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Schiff bases prepared by the reactions of substituted amines with indole-/, pyrimidine-/, pyridine-/, and quinoline-aldehydes are made to undergo indium mediated allylation whereby a (substituted amine, allyl)methyl group has been introduced at C-3 of indole, C-5 of pyrimidine, and C-2 of pyridine and quinoline. Amongst the 16 compounds investigated for anti-cancer activities at 59 human tumor cell lines 3, 9-12, and 14 show appreciable activities. The structure-activity relationship studies point that the contribution of phenylglycinol moiety as a part of side chain at C-3 of indole and C-5 of pyrimidine seems to be crucial for exhibiting anti-cancer activities. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2386 / 2395
页数:10
相关论文
共 42 条
[1]  
ALLEY MC, 1988, CANCER RES, V48, P589
[2]   Substituted E-3-(2-chloro-3-indolylmethylene)1, 3-dihydroindol-2-ones with antitumor activity [J].
Andreani, A ;
Granaiola, M ;
Leoni, A ;
Locatelli, A ;
Morigi, R ;
Rambaldi, M ;
Garaliene, V ;
Farruggia, G ;
Masotti, L .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (05) :1121-1128
[3]   New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists [J].
Baraldi, PG ;
Tabrizi, MA ;
Preti, D ;
Bovero, A ;
Fruttarolo, F ;
Romagnoli, R ;
Zaid, NA ;
Moorman, AR ;
Varani, K ;
Borea, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (15) :5001-5008
[4]   Toward a versatile allylation reagent: Practical, enantioselective allylation of acylhydrazones using strained silacycles [J].
Berger, R ;
Rabbat, PMA ;
Leighton, JL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (32) :9596-9597
[5]   Organometallic reactions in aqueous media:: Indium-promoted additions to 2-pyridyl and glyoxylic acid oxime ethers [J].
Bernardi, L ;
Cerè, V ;
Femoni, C ;
Pollicino, S ;
Ricci, A .
JOURNAL OF ORGANIC CHEMISTRY, 2003, 68 (08) :3348-3351
[6]   C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging [J].
Breyholz, HJ ;
Schäfers, M ;
Wagner, S ;
Höltke, C ;
Faust, A ;
Rabeneck, H ;
Levkau, B ;
Schober, O ;
Kopka, K .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (09) :3400-3409
[7]   THE CATALYTIC MECHANISM AND STRUCTURE OF THYMIDYLATE SYNTHASE [J].
CARRERAS, CW ;
SANTI, DV .
ANNUAL REVIEW OF BIOCHEMISTRY, 1995, 64 :721-762
[8]   Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs [J].
Charlier, C ;
Michaux, C .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (7-8) :645-659
[9]   A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline [J].
Davioud-Charvet, E ;
Delarue, S ;
Biot, C ;
Schwöbel, B ;
Boehme, CC ;
Müssigbrodt, A ;
Maes, L ;
Sergheraert, C ;
Grellier, P ;
Schirmer, RH ;
Becker, K .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (24) :4268-4276
[10]   New trends in dual 5-LOX/COX inhibition [J].
de Leval, X ;
Julémont, F ;
Delarge, J ;
Pirotte, B ;
Dogné, JM .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (09) :941-962